A tale of two alleles: TP53 and transformation in MPNs

Similar Items

• Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
  by: Davidson Zhao, et al.
  Published: (2023-03-01)
• MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
  by: Hans Carl Hasselbalch, et al.
  Published: (2015-01-01)
• Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
  by: Melania Tesio
  Published: (2023-02-01)
• Philadelphia Negative MPNs, MDS/MPNs and MDS in the Context of Recent WHO Changes and Inclusion of Molecular Signatures into Prognostic Tools: A Single Centre Experience
  by: Neha Singh, et al.
  Published: (2023-01-01)
• Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
  by: Bernard, E, et al.
  Published: (2020)